ANTIBODIES BINDING TO HUMAN PAD4 AND USES THEREOF Application WO-2024020579-A1 World Intellectual Property Organisation (WIPO) 25 Jan 2024
Tolerogenic synthetic nanocarriers for allergy therapy Grant US-11779641-B2 United States of America 10 Oct 2023
Methods and compositions for attenuating anti-viral transfer vector immune responses Grant US-11633422-B2 United States of America 25 Apr 2023
IMPROVED Fc SILENCED ANTI-oxMIF ANTIBODIES WITH REDUCED AGGREGATION POTENTIAL AND REDUCED… Application WO-2023031397-A1 World Intellectual Property Organisation (WIPO) 09 Mar 2023
Anti-E-selectin antibodies, compositions and methods of use Grant US-11597770-B2 United States of America 07 Mar 2023
Antibodies specific for GUCY2c and uses thereof Grant US-11525010-B2 United States of America 13 Dec 2022
Methods and compositions related to combined treatment with antiinflammatories and… Grant US-11426451-B2 United States of America 30 Aug 2022
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-11298342-B2 United States of America 12 Apr 2022
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-11235057-B2 United States of America 01 Feb 2022
EPITOPE-BASED VACCINES FOR TREATMENT OF CORONAVIRUS ASSOCIATED DISEASES Application WO-2021198999-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS Application EP-3871691-A1 European Patent Office 01 Sep 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES Application EP-3848030-A1 European Patent Office 14 Jul 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES Application EP-3760201-A1 European Patent Office 06 Jan 2021
CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS Application EP-3682878-A1 European Patent Office 22 Jul 2020
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS Application EP-3679933-A1 European Patent Office 15 Jul 2020
Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-al… Grant US-10668053-B2 United States of America 02 Jun 2020
ANTIBODIES SPECIFIC FOR GUCY2C AND USES THEREOF Application WO-2019224716-A2 World Intellectual Property Organisation (WIPO) 28 Nov 2019
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Grant US-10441651-B2 United States of America 15 Oct 2019
Methods related to administering immunosuppressants and therapeutic macromolecules at a… Grant US-10434088-B2 United States of America 08 Oct 2019
Timothy grass allergens and methods and uses for immune response modulation Grant US-10428124-B2 United States of America 01 Oct 2019
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells Grant US-10420835-B2 United States of America 24 Sep 2019
Methods comprising dosing combinations for reducing undesired humoral immune responses Grant US-10357483-B2 United States of America 23 Jul 2019
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-10357482-B2 United States of America 23 Jul 2019
Methods of administering immunosuppressants having a specified pharmacodynamic effective… Grant US-10335395-B2 United States of America 02 Jul 2019
Mucin-associated surface protein as a vaccine against chagas disease Grant US-10279023-B2 United States of America 07 May 2019
KIF20A epitope peptides for TH1 cells and vaccines containing the same Grant US-10172926-B2 United States of America 08 Jan 2019
Methods and compositions for attenuating gene expression modulating anti-viral transfer… Grant US-10071114-B2 United States of America 11 Sep 2018
Methods and compositions for attenuating exon skipping anti-viral transfer vector immune… Grant US-10046064-B2 United States of America 14 Aug 2018
Method for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-10039822-B2 United States of America 07 Aug 2018
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Grant US-10004802-B2 United States of America 26 Jun 2018
Tolerogenic synthetic nanocarriers for inducing regulatory B cells Grant US-9993548-B2 United States of America 12 Jun 2018
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells Grant US-9987354-B2 United States of America 05 Jun 2018
LY6K epitope peptides for TH1 cells and vaccines containing the same Grant US-9644010-B2 United States of America 09 May 2017
Mucin-associated surface protein as vaccine against Chagas disease Grant US-9566320-B2 United States of America 14 Feb 2017
KIF20A epitope peptides for TH1 cells and vaccines containing the same Grant US-9561265-B2 United States of America 07 Feb 2017
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RHINOVIRUS INFECTIONS Application WO-2016134288-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2016
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins Grant US-9295718-B2 United States of America 29 Mar 2016
Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses Grant US-9289477-B2 United States of America 22 Mar 2016
IMMUNE MOTIFS IN PRODUCTS FROM DOMESTIC ANIMALS Application WO-2016007871-A2 World Intellectual Property Organisation (WIPO) 14 Jan 2016
GRASS POLLEN IMMUNOGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION Application WO-2015077442-A2 World Intellectual Property Organisation (WIPO) 28 May 2015
PAN POLLEN IMMUNOGENS AND METHODS AND USES FOR IMMUNE RESPONSE MODULATION Application WO-2015077434-A2 World Intellectual Property Organisation (WIPO) 28 May 2015
METHOD FOR PREDICTION OF AN IMMUNE RESPONSE AGAINST MISMATCHED HUMAN LEUKOCYTE ANTIGENS Application WO-2014072467-A1 World Intellectual Property Organisation (WIPO) 15 May 2014
Tolerogenic synthetic nanocarriers for inducing regulatory B cells Grant US-8652487-B2 United States of America 18 Feb 2014
MODULAR VACCINES, METHODS AND COMPOSITIONS RELATED THERETO Application WO-2013093629-A2 World Intellectual Property Organisation (WIPO) 27 Jun 2013
SYNTHETIC NANOCARRIERS THAT GENERATE HUMORAL AND CYTOTOXIC T LYMPHOCYTE (CTL) IMMUNE… Application WO-2013019669-A2 World Intellectual Property Organisation (WIPO) 07 Feb 2013
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY Application WO-2012149268-A1 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+REGULATORY T CELLS Application WO-2012149282-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS Application WO-2012149393-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2012
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR INDUCING REGULATORY B CELLS Application WO-2012149301-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2012
COMPOSITIONS AND METHOD FOR DEIMMUNIZATION OF PROTEINS Application WO-2012075173-A2 World Intellectual Property Organisation (WIPO) 07 Jun 2012